The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy (Q35208652)

7 August 2017

title

The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy (English)

1 reference

7 August 2017

0 references

John L Zapas

1 reference

7 August 2017

H Christopher Coley

1 reference

7 August 2017

Sandra L Beam

1 reference

7 August 2017

Sally D Brown

1 reference

7 August 2017

Kathleen A Jablonski

1 reference

7 August 2017

E George Elias

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Journal of the American College of Surgeons

7 August 2017

published in

1 reference

7 August 2017

volume

197

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

403-407

1 reference

Establishing a standard of care for the patient with melanoma

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

"Epidemic" of malignant melanoma: true increase or better detection?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Molecular staging of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

The predictive value of the sentinel lymph node in malignant melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900432-0

7 January 2021

10.1016/S1072-7515(03)00432-0

Identifiers

DOI

1 reference

7 August 2017

1 reference